Linde Healthcare, a global business of the Linde Group, has announced the three grantees of its REALfund initiative, who will receive funds to support their innovative research in the healthcare sector.
Although the amounts of the funds were not disclosed, the REALfund initiative supports ideas and projects with the potential to improve patient outcomes and health economics across the respiratory medicine sector.
The first of the three beneficiaries are PD Johannes Bickenbach MD and Prof. Michael Dreher MD from Germany, who are investigating exacerbations of invasively mechanically ventilated chronic obstructive pulmonary disease (COPD) patients.
The second grantee, Thomas Bitter MD, will use the funds to study if high flow oxygen (O2) therapy can serve as a therapeutic approach to patients suffering from Cheyne-Stokes respiration, also based in Germany.
... to continue reading you must be subscribed
